Chronic <scp>mTOR</scp> inhibition in mice with rapamycin alters <scp>T</scp> , <scp>B</scp> , myeloid, and innate lymphoid cells and gut flora and prolongs life of immune‐deficient mice
Vincent Hurez(The University of Texas at San Antonio Health Science Center), Tyler J. Curiel(Tulane University), Z. Dave Sharp(Mays Cancer Center at UT Health San Antonio), Verónica Galván(University of Oklahoma Health Sciences Center), Justin Drerup(The University of Texas at Dallas), Molly A. Bergman(The University of Texas at San Antonio Health Science Center), Yang Liu(Mudanjiang Medical University), Aijie Liu(The University of Texas at San Antonio Health Science Center), Carlos J. Orihuela, Vinh Dao(The University of Texas at San Antonio Health Science Center), Álvaro Padrón(Universidade Federal do Rio de Janeiro), Lishi Sun(The University of Texas at San Antonio Health Science Center), Paul Hasty(The University of Texas at San Antonio Health Science Center), Srilakshmi Pandeswara(The University of Texas at San Antonio Health Science Center), Jonathan Gelfond(The University of Texas at San Antonio Health Science Center)
Cited by 128
Related Papers
Interventions to Slow Aging in Humans: Are We Ready?
|Aging Cell|2015|598
Aging and Genome Maintenance: Lessons from the Mouse?
|Science|2003|548
Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma
|Cancer Research|2016|399
Combined autophagy and HDAC inhibition
|Autophagy|2014|292